Results 251 to 260 of about 177,224 (285)

Classical complement pathway factor alterations in narcolepsy

Acta Neuropsychiatrica, 2022
AbstractObjective:Narcolepsy is a chronic sleep disorder long hypothesised to be an autoimmune disease. Complement-mediated immune mechanisms have not been investigated in detail in narcolepsy. Our aim was to establish the significance of classical pathway activation in narcolepsy.Methods:Sera of 42 narcolepsy patients and 26 healthy controls were ...
Hande Yüceer   +7 more
openaire   +3 more sources

Classical pathway complement activity in schizophrenia

Neuroscience Letters, 2005
There is considerable evidence to suggest a role for complement in the pathogenesis of schizophrenia, but the data related to the classical pathway complement activity in patients with schizophrenia are conflicting. In the present study, the total hemolytic activity of the complement and the activities of individual complement components, C1, C2, C3 ...
Svetlana, Hakobyan   +2 more
openaire   +2 more sources

Classical pathway complement activation in Kawasaki syndrome

Journal of Allergy and Clinical Immunology, 1994
In this study the complement breakdown products C3d, C4d, Bb and membrane attack complex were measured in plasma of patients with Kawasaki syndrome. The results suggested strong activation of the classical activation pathway. However, there was no significant decrease in hemolytic titer or in the concentrations of the intact proteins C3, C4, and B. The
T, Kohsaka   +3 more
openaire   +2 more sources

Classical pathway complement activity in Familial Mediterranean fever

Clinical Biochemistry, 2006
The present study emphasizes the important role of the immune reactions in the pathogenesis of Familial Mediterranean fever. In the present study, the total hemolytic activity of the complement and the activities of individual complement components, C1, C2, C3, and C4, were determined in the blood serum of 32 patients with FMF and 28 healthy subjects ...
G M, Mkrtchyan   +3 more
openaire   +2 more sources

Targeting Classical Complement Pathway to Treat Complement Mediated Autoimmune Diseases

2008
Mice deficient for classical complement pathway (CCP) factor C4 are resistant to antibody and complement mediated experimental autoimmune myasthenia gravis (EAMG). Anti-C1q antibody administration before or following acetylcholine receptor immunization suppresses EAMG development by reducing lymph node cell IL-6 production and neuromuscular junction ...
Erdem, Tüzün   +4 more
openaire   +2 more sources

Activation of the classical complement pathway by BioRex-70

Immunology Letters, 1987
The cation exchange resin BioRex-70 was able to activate the classical complement pathway in human serum at 37 degrees C over the resin concentration range 0-5% (v/v). Using zymosan-treated human serum, it was found that the activation proceeded as far as complement protein C3.
R J, Vandenberg, S B, Easterbrook-Smith
openaire   +2 more sources

Effect of Concanavalin A on the Classical Complement Pathway

The Journal of Immunology, 1977
Abstract Lysis of sheep erythrocytes (E) sensitized with anti-Forssman antiserum (EA) is inhibited by the action of concanavalin A (Con A) on whole guinea pig complement (GPC). The degree of inhibition observed for a given quantity of GPC was dependent on the Con A concentration.
J J, Langone, M D, Boyle, T, Borsos
openaire   +2 more sources

The non-classical functions of the classical complement pathway recognition subcomponent C1q

Immunology Letters, 2010
C1q, the ligand recognition subcomponent of the classical complement pathway has steadily been gaining recognition as a bridge between innate and adaptive immunity. C1q has been shown to be involved in the modulation of various immune cells (such as dendritic cells, platelets, microglia cells and lymphocytes), clearance of apoptotic cells, a range of ...
Annapurna, Nayak   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy